Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $410,188.00 |
|---|---|
| Enterprise Value | $17.01 Million |
| Earnings per Share | $-0.08 |
| Beta | 4.14 |
| Outstanding Shares | 7,134,000 |
| P/E Ratio | -0.58 |
|---|---|
| PEG | -3.51 |
| Price to Sales | 0.03 |
| Price to Book Ratio | -0.05 |
| Enterprise Value to Revenue | 1.04 |
| Enterprise Value to EBIT | -1.12 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.25 |
| Debt to Equity | -6.93 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Paion AG operates as a specialized pharmaceutical entity, concentrating its efforts on creating and selling groundbreaking treatments within the realms of anesthesia, intensive care, and critical care medicine. The company places particu...